RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mezzion Pharma Co Stock

Mezzion Pharma Co Net Income 2024

Mezzion Pharma Co Net Income

-12.73 B KRW

Ticker

140410.KQ

ISIN

KR7140410002

In 2024, Mezzion Pharma Co's profit amounted to -12.73 B KRW, a -64.93% increase from the -36.3 B KRW profit recorded in the previous year.

The Mezzion Pharma Co Net Income history

YEARNET INCOME (undefined KRW)
2023-12.73
2022-36.3
2021-13.6
2020-13.83
2019-23.25
2018-18.88
2017-14.88
2016-12.99
20154.22
2014-2.57
2013-0.83
20122.39
20113.2
201017.07
200911.57
2008-2.23

Mezzion Pharma Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Mezzion Pharma Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Mezzion Pharma Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Mezzion Pharma Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Mezzion Pharma Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Mezzion Pharma Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Mezzion Pharma Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Mezzion Pharma Co’s growth potential.

Mezzion Pharma Co Revenue, EBIT and net profit per share

DateMezzion Pharma Co RevenueMezzion Pharma Co EBITMezzion Pharma Co Net Income
202331.72 B undefined-14.49 B undefined-12.73 B undefined
202230.73 B undefined-23.33 B undefined-36.3 B undefined
202126.65 B undefined-16.8 B undefined-13.6 B undefined
202028.63 B undefined-7.53 B undefined-13.83 B undefined
201917.92 B undefined-24.72 B undefined-23.25 B undefined
201819.09 B undefined-21.93 B undefined-18.88 B undefined
20175.59 B undefined-16.85 B undefined-14.88 B undefined
20168.75 B undefined-7.22 B undefined-12.99 B undefined
201514.93 B undefined-2.73 B undefined4.22 B undefined
20144.86 B undefined-4.92 B undefined-2.57 B undefined
20134.4 B undefined-2.47 B undefined-831 M undefined
20128.59 B undefined1.68 B undefined2.39 B undefined
20115.07 B undefined2.93 B undefined3.2 B undefined
201024.25 B undefined17.64 B undefined17.07 B undefined
200918.44 B undefined12.97 B undefined11.57 B undefined
2008206 M undefined-2.66 B undefined-2.23 B undefined

Mezzion Pharma Co stock margins

The Mezzion Pharma Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mezzion Pharma Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mezzion Pharma Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Mezzion Pharma Co's sales revenue. A higher gross margin percentage indicates that the Mezzion Pharma Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Mezzion Pharma Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Mezzion Pharma Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Mezzion Pharma Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Mezzion Pharma Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Mezzion Pharma Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Mezzion Pharma Co Margin History

Mezzion Pharma Co Gross marginMezzion Pharma Co Profit marginMezzion Pharma Co EBIT marginMezzion Pharma Co Profit margin
202312.25 %-45.68 %-40.13 %
2022-1.02 %-75.93 %-118.13 %
202113.88 %-63.02 %-51.03 %
202025.98 %-26.3 %-48.3 %
201916.19 %-137.93 %-129.75 %
201816.96 %-114.87 %-98.89 %
201716.09 %-301.58 %-266.42 %
201656.72 %-82.5 %-148.38 %
201565.85 %-18.31 %28.29 %
201450.28 %-101.21 %-52.87 %
201356.72 %-56.18 %-18.88 %
201274.3 %19.55 %27.76 %
2011100 %57.73 %63.23 %
201012.25 %72.75 %70.4 %
200912.25 %70.35 %62.73 %
200812.25 %-1,290.29 %-1,082.04 %

Mezzion Pharma Co Aktienanalyse

What does Mezzion Pharma Co do?

Mezzion Pharma Co Ltd is a biopharmaceutical company based in South Korea, focused on the development and commercialization of therapeutics for the treatment of heart diseases. The company was founded in 2009 and has been listed on the Korea Stock Exchange since 2014. Mezzion Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Mezzion Pharma Co's Profit Margins

The profit margins of Mezzion Pharma Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Mezzion Pharma Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Mezzion Pharma Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Mezzion Pharma Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Mezzion Pharma Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Mezzion Pharma Co stock

How much profit has Mezzion Pharma Co made this year?

Mezzion Pharma Co has made -12.73 B KRW this year.

How has the profit developed compared to last year?

The profit has increased by -64.93% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Mezzion Pharma Co publish its earnings?

Mezzion Pharma Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Mezzion Pharma Co?

The profits of Mezzion Pharma Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Mezzion Pharma Co?

You can learn more about the earnings of Mezzion Pharma Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Mezzion Pharma Co pay?

Over the past 12 months, Mezzion Pharma Co paid a dividend of 8.33 KRW . This corresponds to a dividend yield of about 0.03 %. For the coming 12 months, Mezzion Pharma Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Mezzion Pharma Co?

The current dividend yield of Mezzion Pharma Co is 0.03 %.

When does Mezzion Pharma Co pay dividends?

Mezzion Pharma Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mezzion Pharma Co?

Mezzion Pharma Co paid dividends every year for the past 0 years.

What is the dividend of Mezzion Pharma Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mezzion Pharma Co located?

Mezzion Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mezzion Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mezzion Pharma Co from 4/1/2013 amounting to 25 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2012.

When did Mezzion Pharma Co pay the last dividend?

The last dividend was paid out on 4/1/2013.

What was the dividend of Mezzion Pharma Co in the year 2023?

In the year 2023, Mezzion Pharma Co distributed 0 KRW as dividends.

In which currency does Mezzion Pharma Co pay out the dividend?

The dividends of Mezzion Pharma Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mezzion Pharma Co

Our stock analysis for Mezzion Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mezzion Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.